Status:

COMPLETED

Fentanyl Versus Midazolam As Additives To Bupivacaine In Ultrasound Guided Transversus Abdominis Plane Block

Lead Sponsor:

Bassant M. Abdelhamid

Conditions:

Postoperative Pain

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Pain triggers a complex biochemical and physiological stress response leading to impairment of pulmonary, immunological and metabolic functions. The Transversus Abdominis Plane (TAP) block, is a regi...

Detailed Description

Informed written consent will be obtained from study participants or their legally authorized representative. This is a randomized controlled double blinded study; patients will be enrolled in the stu...

Eligibility Criteria

Inclusion

  • Physical status ASA I and ASA ll.
  • Age ≥ 18 and ≤ 65 Years.
  • Body mass index (BMI): ≥ 20 kg/m2 and ≤ 35 kg/m2.
  • Patients undergoing Abdominal Surgeries.
  • Patient is able to provide a written informed consent.

Exclusion

  • Known sensitivity to local anaesthetics.
  • Significant liver or renal insufficiency.
  • Contraindication to regional anaesthesia e.g. local - sepsis, pre-existing peripheral neuropathies and coagulopathy.
  • Patient refusal.
  • Failed Block.

Key Trial Info

Start Date :

June 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 15 2024

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04426617

Start Date

June 10 2020

End Date

June 15 2024

Last Update

July 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cairo university

Cairo, Egypt

Fentanyl Versus Midazolam As Additives To Bupivacaine In Ultrasound Guided Transversus Abdominis Plane Block | DecenTrialz